EASTERN AFRICA CONSORTIUM FOR CLINICAL RESEARCH 4core

EACCR4 · Horizon Europe grant · 2026-06-01–2030-05-31

EC contribution

€12,751,649

Total cost

€0

Beneficiaries

About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-JU-GH-EDCTP3-2025-03-two-stage · scheme HORIZON-JU-CSA · topic HORIZON-JU-GH-EDCTP3-2025-03-NETWORKS-01-two-stage. CORDIS record →

Objective

The overall objective of the Eastern Africa Consortium for Clinical Research 4 (EACCR4) is to be the leading network with comprehensive clinical research eco-system capabilities to support clinical research in response to poverty-related diseases, and epidemics and outbreaks in the Eastern Africa region. The EACCR4 network consists of 22 partners (SSA:12; North:10), excluding EDCTP, from 13 countries with 7 SSA including DRC, Somalia and Zambia as new members. Eleven (11) of the partners are new to the network. We shall achieve our objectives through 10 work packages which are grouped into four platforms:1) Clinical and Laboratory; 2) Ethics, Training, and Stakeholder engagement; 3) Epidemics Research and Response 4) Research Support and coordination. Our strategy will be to build capacity for ICH-GCP research in the region by leveraging the expertise and experience of centers of excellence to build the capacity of the institutions and partners with low capacity for research. Special focus will be laid on building capacity for research on epidemics and outbreaks which are very common in the East African Region. We shall work with the national institutes of public health to establish an acute febrile illness surveillance system that will enhance the capacity for research in event of an outbreak. We propose to establish a training and mentorship platform that will support scientists to become global research leaders conducting cutting-edge research responsive to the needs of the region. The network will increase the volume of clinical research to inform policy, providing solutions to health challenges, and contributing to achieving health for all SDG3 goal in Eastern Africa.

Beneficiaries (23)

Organisation	Country	Role	EC contribution
EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP	NL	coordinator	€1
UGANDA NATIONAL HEALTH RESEARCH ORGANISATION	UG	participant	€1,635,127
KENYA MEDICAL RESEARCH INSTITUTE	KE	participant	€1,384,325
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN	DE	participant	€1,044,880
THE GOOD SAMARITAN FOUNDATION	TZ	participant	€772,569
NATIONAL INSTITUTE FOR MEDICAL RESEARCH	TZ	participant	€681,345
RWANDA BIOMEDICAL CENTER	RW	participant	€643,752
UNIVERSITE CATHOLIQUE DE BUKAVU	CD	participant	€614,142
UNIVERSITY OF RWANDA	RW	participant	€568,010
THE INFECTIOUS DISEASES INSTITUTE LIMITED	UG	participant	€526,962
MAKERERE UNIVERSITY LUNG INSTITUTE	UG	participant	€496,875
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER	UK	participant	€488,899
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS	UK	participant	€476,750
KAROLINSKA INSTITUTET	SE	participant	€404,997
Council of the University of Zambia	ZM	participant	€383,270
STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT	NL	participant	€382,390
KOBENHAVNS UNIVERSITET	DK	participant	€350,001
IAVI AFRICA LIMITED	KE	participant	€343,594
UNIVERSITETET I OSLO	NO	participant	€333,806
AFRICA RESEARCH EXCELLENCE FUND	UK	participant	€309,850
NATIONAL INSTITUTE OF HEALTH OF SOMALIA	SO	participant	€306,375
CHARITE - UNIVERSITAETSMEDIZIN BERLIN	DE	participant	€303,730
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	UK	participant	€299,999

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.

Objective

Beneficiaries (23)

Get the DFM funding briefing — free